ArticleAmerican journal of translational research2025

Effects of nedaplatin combined with paclitaxel liposomes or docetaxel on survival rate and biomarkers in patients with recurrent ovarian cancer.

Jie Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.